Lincoln National Corp’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,157
| Closed | -$249K | – | 127 |
|
|
2024
Q1 | $249K | Sell |
1,157
-55
| -5% | -$11.9K | ﹤0.01% | 1042 |
|
|
2023
Q4 | $314K | Sell |
1,212
-244
| -17% | -$63.1K | 0.01% | 856 |
|
|
2023
Q3 | $374K | Sell |
1,456
-8,363
| -85% | -$2.15M | 0.01% | 698 |
|
|
2023
Q2 | $2.8M | Sell |
9,819
-324
| -3% | -$92.3K | 0.06% | 191 |
|
|
2023
Q1 | $2.82M | Buy |
10,143
+1,743
| +21% | +$485K | 0.06% | 185 |
|
|
2022
Q4 | $2.33M | Buy |
+8,400
| New | +$2.33M | 0.05% | 202 |
|
|
2022
Q1 | – | Sell |
-1,121
| Closed | -$269K | – | 917 |
|
|
2021
Q4 | $269K | Buy |
1,121
+36
| +3% | +$8.64K | 0.01% | 755 |
|
|
2021
Q3 | $307K | Sell |
1,085
-1,920
| -64% | -$543K | 0.01% | 671 |
|
|
2021
Q2 | $1.04M | Buy |
3,005
+1,878
| +167% | +$651K | 0.02% | 311 |
|
|
2021
Q1 | $315K | Sell |
1,127
-318
| -22% | -$88.9K | 0.01% | 603 |
|
|
2020
Q4 | $354K | Sell |
1,445
-375
| -21% | -$91.9K | 0.01% | 526 |
|
|
2020
Q3 | $516K | Buy |
1,820
+254
| +16% | +$72K | 0.02% | 378 |
|
|
2020
Q2 | $419K | Buy |
1,566
+708
| +83% | +$189K | 0.01% | 409 |
|
|
2020
Q1 | $272K | Buy |
858
+3
| +0.4% | +$951 | 0.01% | 469 |
|
|
2019
Q4 | $254K | Buy |
+855
| New | +$254K | 0.01% | 538 |
|
|
2019
Q3 | – | Sell |
-1,030
| Closed | -$241K | – | 580 |
|
|
2019
Q2 | $241K | Sell |
1,030
-99
| -9% | -$23.2K | 0.01% | 481 |
|
|
2019
Q1 | $267K | Buy |
+1,129
| New | +$267K | 0.01% | 412 |
|
|
2018
Q1 | – | Sell |
-962
| Closed | -$306K | – | 499 |
|
|
2017
Q4 | $306K | Buy |
+962
| New | +$306K | 0.01% | 492 |
|